Genetic Variants in ECM Protease Genes and Rheumatoid Arthritis Risk
Author Information
Author(s): Rodriguez-Lopez Julio, Perez-Pampin Eva, Gomez-Reino Juan J, Gonzalez Antonio
Primary Institution: Hospital Clinico Universitario de Santiago, University of Santiago de Compostela, Spain
Hypothesis
Are single nucleotide polymorphisms (SNPs) in extracellular matrix protease genes associated with susceptibility to rheumatoid arthritis?
Conclusion
The study found modest associations between two SNPs in ECM protease genes and rheumatoid arthritis susceptibility, suggesting a potential protective role for these genes.
Supporting Evidence
- Two SNPs showed significant association with RA susceptibility.
- RA patients had higher frequencies of specific alleles compared to controls.
- The study included a large sample size of RA patients and controls.
- Findings suggest a protective role for certain ECM proteases in RA pathology.
Takeaway
Scientists looked at genes that help break down tissues in the body to see if changes in these genes make people more likely to get rheumatoid arthritis. They found some changes that might be linked to the disease.
Methodology
The study involved genotyping nine SNPs in ECM protease genes in a case-control setting with 550 RA patients and 652 controls.
Potential Biases
Population stratification was minimized as all participants were of Spanish ancestry from a homogenous region.
Limitations
The study may not account for all genetic factors influencing RA susceptibility and the associations need replication.
Participant Demographics
The study included 550 RA patients (76.5% female) and 652 controls (52.8% female), all of Spanish ancestry.
Statistical Information
P-Value
0.013 for MMP2, 0.026 for PLAT
Confidence Interval
95% CI 1.02–1.43 for PLAT, 95% CI 1.05–1.55 for MMP2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website